Longevity & Heart Health

    Vitamin K2 (MK-7) for Heart Health: Can It Protect Your Arteries?

    Peak Human · Reviewed by Dr. Sanjeev GoelJuly 23, 2026~6 min read

    Your arteries are supposed to stay soft and flexible. Over time, calcium can build up in their walls — a process called arterial calcification that stiffens the arteries and is one of the strongest predictors of heart attacks and strokes. A growing body of research suggests that one nutrient, Vitamin K2 (MK-7), may help keep that calcium where it belongs: in your bones, not your blood vessels.

    The 30-second takeaway

    • Vitamin K2 activates a protein (matrix Gla protein) that helps stop calcium from depositing in artery walls.[1]
    • A 2-year, 180-person randomized trial published in JAMA Cardiology (2026) found MK-7 slowed coronary artery calcification progression by about 29%.[1]
    • Earlier trials show MK-7 can improve arterial stiffness and vitamin K status, especially in higher-risk adults.[2][3]
    • It has an excellent safety record — but it interacts with blood thinners, so talk to your doctor first.

    Peak Human Shop

    Support your heart health with a high-potency, bioavailable MK-7.

    Shop Megaquinone (Vitamin K2 MK-7) →

    Why calcium in your arteries is a problem

    Calcium is essential — but only in the right places. When arteries accumulate calcium, they become rigid and less able to expand and contract with each heartbeat. Coronary artery calcification (CAC) is now considered one of the best imaging markers of atherosclerosis and an independent predictor of cardiovascular events.[1] The frustrating part for doctors is that, until recently, there have been very few proven ways to slow it down.

    This is where Vitamin K2 enters the picture. Your body makes a protein called matrix Gla protein (MGP), one of the most powerful natural inhibitors of vascular calcification. But MGP only works when it is "activated" by Vitamin K. When your Vitamin K status is low, MGP stays in its inactive form and calcium is freer to deposit in the vessel wall.[1]

    "When Vitamin K status is insufficient, matrix Gla protein cannot perform its calcification-inhibiting function."

    What the 2026 trial actually found

    The strongest evidence to date comes from the VitaK-CAC study, published in JAMA Cardiology in 2026.[1] Researchers randomized 180 adults with existing coronary artery disease to either 360 mcg of MK-7 daily or a placebo, and tracked their calcification with CT scans over two years.

    The MK-7 group showed roughly 29% less progression in their Agatston calcium score and about 42% less progression in calcium mass — a more precise measure of the calcification process. Blood tests confirmed the mechanism: MK-7 takers had lower levels of inactive MGP, meaning more of the protein was switched "on" to protect their arteries.[1]

    Figure 1

    Less coronary calcification progression with MK-7 vs. placebo

    VitaK-CAC randomized trial, 2 years, 360 mcg/day MK-7 — JAMA Cardiology 2026

    Stiffer arteries, softened

    Calcification is only part of the story — arterial stiffness matters too. In a landmark 3-year trial, 244 healthy postmenopausal women taking 180 mcg of MK-7 daily saw measurable improvements in arterial stiffness compared with placebo.[2] A more recent one-year analysis of 165 women with low Vitamin K status echoed this: in postmenopausal women, arterial stiffness climbed by roughly 49% in the placebo group but only about 9% with MK-7.[3]

    Figure 2

    One-year change in arterial stiffness (postmenopausal women)

    180 mcg/day MK-7 vs placebo, low vitamin K status — Nutrients 2025

    Results aren't universal. In a 2023 trial of chronic dialysis patients — a very high-risk group — MK-7 did not significantly improve overall arterial stiffness, though it did help the subgroup with diabetes.[4] This is a useful reminder that supplements work best as part of a broader prevention strategy, not as a rescue for advanced disease.

    Dosage, food sources, and safety

    Vitamin K2 (MK-7) is found in small amounts in fermented foods like natto, some cheeses, and egg yolks, but most people get very little. Trials showing cardiovascular benefit have used doses of 180–360 mcg of MK-7 per day.[1][2] MK-7 is the preferred form because it stays active in the bloodstream far longer than the shorter-acting MK-4.

    Vitamin K2 has a strong safety profile, with no established toxic upper limit for healthy adults. The critical exception: if you take a Vitamin K antagonist blood thinner such as warfarin, Vitamin K directly counteracts the medication — do not start it without medical supervision.

    Peak Human Shop

    Peak Human's Megaquinone delivers a clinically-relevant MK-7 dose in a single daily capsule.

    Get Megaquinone (Vitamin K2 MK-7) →

    The bottom line

    Vitamin K2 (MK-7) won't replace exercise, a good diet, or the medications your doctor prescribes. But the evidence — now anchored by a rigorous 2026 randomized trial — suggests it's one of the more promising nutrients for supporting long-term arterial health, working through a clear, well-understood biological mechanism. For anyone thinking seriously about cardiovascular longevity, it's a nutrient worth discussing with your healthcare provider.

    This content is for educational purposes only and is not medical advice. Some findings, particularly around hard cardiovascular outcomes, remain preliminary and are based on surrogate markers like calcification scores. Always consult a qualified healthcare provider before starting any supplement, especially if you take blood thinners or have a heart condition.

    References

    1. [1]Vossen LM, de Leeuw PW, Schurgers LJ, et al. Two years of menaquinone-7 supplementation and coronary artery calcification: a randomized clinical trial (VitaK-CAC). JAMA Cardiology. 2026. doi:10.1001/jamacardiology.2026.2850. View source
    2. [2]Knapen MHJ, Braam LAJLM, Drummen NE, et al. Menaquinone-7 supplementation improves arterial stiffness in healthy postmenopausal women: a double-blind randomised clinical trial. Thrombosis and Haemostasis. 2015;113(5):1135–1144. View source
    3. [3]Effects of one-year menaquinone-7 supplementation on vascular stiffness and blood pressure in pre-, peri-, and post-menopausal women. Nutrients. 2025;17(5):815. View source
    4. [4]Effect of menaquinone-7 supplementation on arterial stiffness in chronic hemodialysis patients: a multicenter randomized controlled trial. Nutrients. 2023;15(11):2422. View source